rs147294932

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 5P and 1B. PM1PM2PP3BS1_Supporting

The NM_001875.5(CPS1):​c.713G>A​(p.Arg238Gln) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000655 in 1,612,580 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00055 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00067 ( 0 hom. )

Consequence

CPS1
NM_001875.5 missense, splice_region

Scores

2
9
8
Splicing: ADA: 0.9889
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 5.39
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM1
In a domain Glutamine amidotransferase type-1 (size 185) in uniprot entity CPSM_HUMAN there are 28 pathogenic changes around while only 3 benign (90%) in NM_001875.5
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000552 (84/152082) while in subpopulation NFE AF= 0.001 (68/67956). AF 95% confidence interval is 0.000809. There are 0 homozygotes in gnomad4. There are 41 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CPS1NM_001875.5 linkuse as main transcriptc.713G>A p.Arg238Gln missense_variant, splice_region_variant 8/38 ENST00000233072.10 NP_001866.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CPS1ENST00000233072.10 linkuse as main transcriptc.713G>A p.Arg238Gln missense_variant, splice_region_variant 8/381 NM_001875.5 ENSP00000233072 P1P31327-1

Frequencies

GnomAD3 genomes
AF:
0.000559
AC:
85
AN:
151964
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000218
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000566
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00102
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000339
AC:
85
AN:
250858
Hom.:
0
AF XY:
0.000310
AC XY:
42
AN XY:
135564
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000231
Gnomad NFE exome
AF:
0.000680
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000666
AC:
973
AN:
1460498
Hom.:
0
Cov.:
31
AF XY:
0.000652
AC XY:
474
AN XY:
726604
show subpopulations
Gnomad4 AFR exome
AF:
0.000240
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.000187
Gnomad4 NFE exome
AF:
0.000842
Gnomad4 OTH exome
AF:
0.000282
GnomAD4 genome
AF:
0.000552
AC:
84
AN:
152082
Hom.:
0
Cov.:
32
AF XY:
0.000551
AC XY:
41
AN XY:
74352
show subpopulations
Gnomad4 AFR
AF:
0.000217
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000566
Gnomad4 NFE
AF:
0.00100
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000716
Hom.:
0
Bravo
AF:
0.000476
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000329
AC:
40
EpiCase
AF:
0.000873
EpiControl
AF:
0.000652

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Congenital hyperammonemia, type I Uncertain:2
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Feb 21, 2020- -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpSep 27, 2022This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 238 of the CPS1 protein (p.Arg238Gln). This variant is present in population databases (rs147294932, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with CPS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 583220). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 16, 2021The c.713G>A (p.R238Q) alteration is located in exon 8 (coding exon 8) of the CPS1 gene. This alteration results from a G to A substitution at nucleotide position 713, causing the arginine (R) at amino acid position 238 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJul 19, 2021Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; Missense variants in nearby residues reported in the Human Gene Mutation Database (Stenson et al., 2014) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.11
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.86
.;D;D
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.63
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.97
D;D;D
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.19
T;T;T
MetaSVM
Uncertain
0.37
D
MutationAssessor
Benign
1.9
.;L;.
MutationTaster
Benign
0.97
D;D
PrimateAI
Uncertain
0.68
T
PROVEAN
Uncertain
-3.6
D;D;.
REVEL
Uncertain
0.59
Sift
Benign
0.034
D;D;.
Sift4G
Uncertain
0.039
D;D;D
Polyphen
0.92
.;P;.
Vest4
0.46
MVP
0.92
MPC
0.36
ClinPred
0.39
T
GERP RS
5.0
Varity_R
0.77
gMVP
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.99
dbscSNV1_RF
Pathogenic
0.79
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147294932; hg19: chr2-211454831; API